Hone places NAD+ injections within a broader membership model. That can appeal to readers who want an ongoing relationship with a service, but it also means the medication price alone does not describe the full financial commitment.
We used Hone’s Basic membership help page to understand its published cost structure. This is a review of available information, not a patient account, pharmacy audit, or endorsement of treatment effectiveness.
The $165 medication estimate excludes membership, onboarding, and optional consultation charges.
The published costs, added up
Hone’s Basic page listed an estimated NAD+ medication cost of $165 per month, separate from a $25 monthly membership and a $25 one-time onboarding charge. Those listed components would total about $215 initially and $190 in a later month, before optional consultations or any prescription-specific changes.
The medication amount is explicitly an estimate. Ask for your actual prescription quote before treating either calculated total as your bill. Our pricing guide keeps estimates separate from firm checkout totals and compares equivalent periods.
Understand what the membership covers
The help page describes lab testing twice per year within Basic, while live video consultations are a separate purchase. That distinction matters if your reason for joining is a conversation about symptoms or laboratory results. Access to a test and a visit to interpret it are different services.
Ask which tests apply to your situation and who reviews an unexpected result. A larger number of biomarkers is not automatically better for every person. Your clinician should explain how testing would change the decision about treatment or the follow-up plan.
Budget for the conversation you want
A reader who wants a scheduled live discussion should verify the current consultation price and any booking window. Do not assume that a membership, lab order, or medication refill automatically includes a lengthy visit.
Write down what you need from the appointment: a review of persistent fatigue, medication interactions, a discussion of NAD+ evidence, or help interpreting results. Ask whether the available consultation can address those needs or whether a primary-care appointment is a more appropriate first step.
Prescribing and dispensing still require verification
Hone’s membership information does not replace an individualized medical assessment. Being able to join a plan does not mean NAD+ is appropriate for you. The clinician must consider your health history and the circumstances of the requested treatment.
Before accepting a prescription, ask for the dispensing pharmacy’s identity, its state authorization, and product-specific handling instructions. Confirm which channel reaches the prescriber and which reaches the pharmacist. The online consultation checklist helps keep those responsibilities clear.
Do not confuse monitoring with proven benefit
A program can offer laboratory testing and follow-up while the evidence for a particular treatment remains limited. Monitoring may answer certain safety or health questions; it does not by itself demonstrate that NAD+ injections improve longevity, everyday energy, or cognition.
The research guide explains why changes in biomarkers are different from changes that patients can feel or use in daily life. Ask which outcome matters for your goal, how it will be measured, and when the treatment plan will be reconsidered.
Compare the model, not just the vial
Hone’s structure differs from a service emphasizing a medication-centered offer. CoreAge Rx describes an offer without a membership fee, while Eden has its own required membership pricing. The more useful comparison is the total cost of the services you actually need.
If you already have a clinician following the same health concerns, ask whether another membership would duplicate care. If coordinated local assessment matters to you, use the state and city directory as a starting point for checking nearby options.
Decide what the broader program is worth to you
Before joining, write down which parts of the membership you expect to use over the next several months. You might value testing, access to a care team, or a particular consultation. Ask for an explanation of how each service relates to your health concern rather than treating the number of included features as a measure of quality.
If you already have recent laboratory results or an established clinician, ask whether the service can consider that information and whether any testing would duplicate existing care. Do not assume that every test panel is necessary simply because it is included. The clinical purpose should be understandable.
Finally, separate a decision to retain membership from a decision to continue NAD+. You may have questions about one without wanting the other. Confirm how each can be changed or stopped, and which charges or commitments remain after that change.
A reasonable next step
Hone may belong on a shortlist for someone who wants to investigate a membership that includes periodic testing. It is less straightforward for a reader comparing medication-only headlines. Request an itemized quote and a clear explanation of the clinical conversation available before committing.
- Separate the NAD+ estimate, membership, onboarding, and visits.
- Confirm which laboratory services apply to your plan.
- Ask how results are reviewed and urgent findings are handled.
- Read cancellation rules for both membership and medication.
- Agree on a meaningful follow-up goal, rather than an open-ended subscription.
Follow the source
References & further reading
- Hone — Basic membership and medication costs
Provider help center. Medication prices are estimates, separate from membership.
- FDA — compounding questions and answers
Compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality.
- FDA — ingredients suitable for sterile compounding
Reports NAD+ injectable adverse events and ingredient-quality concerns.
- Grant et al. (2019) — human NAD+ infusion pilot
Small IV metabolism study; does not establish benefits of home injections.